Corinne le Goff - 23 May 2024 Form 4 Insider Report for Longboard Pharmaceuticals, Inc.

Reporting relationship: Director
Issuer ticker: N/A
Reported as of: 23 May 2024
Net transaction value: $0
SEC form: 4
Accepted by SEC: 24 May 2024, 16:15:26 UTC
Prior SEC filing: 19 Apr 2024
Next SEC filing: 02 Dec 2024
Source filing: View source filing
Reporting owner signature: /s/ Andrew J. Cronauer, Attorney-In-Fact

Key filing fact

Corinne le Goff filed Form 4 for Longboard Pharmaceuticals, Inc. on 24 May 2024.

Key facts

This page summarizes Corinne le Goff's Form 4 filing for Longboard Pharmaceuticals, Inc..
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 24 May 2024, 16:15.

Change

Previous filing in this sequence was filed on 19 Apr 2024.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

LBPH transaction Derivative

Stock Option (Right to Buy)

Award

Transaction value: $0
Shares: +22,500
Change %
Price: $0.000000
Shares after: 22,500
Date: 23 May 2024
Ownership: Direct
Underlying class: Voting common stock
Underlying amount: 22,500
Exercise price: $18.94
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

The shares subject to the stock option vest and become exercisable in 12 equal monthly installments commencing June 23, 2024, and in any event will become fully vested on the day before the Company's next annual meeting of stockholders.